Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects
- PMID: 6151507
- DOI: 10.1007/BF00556889
Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects
Abstract
The acute haemodynamic effects of increasing doses of parenterally administered prenalterol-a beta-adrenergic stimulating drug-were assessed in normal subjects by means of radionuclide ventriculography. Prenalterol induced dose-related increases in the left ventricular ejection fraction and the systolic pressure end-systolic volume ratio. Left ventricular end-systolic and end-diastolic volumes decreased to the same extent accounting for an unchanged stroke volume. Cardiac output increased due to a rise in the heart rate. Systolic blood pressure increased, whereas diastolic and mean blood pressure remained unchanged. Calculated total peripheral resistance decreased significantly. The maximum effect of prenalterol on cardiac performance occurred with a dose of 18 to 36 micrograms/kg. Plasma concentrations of prenalterol showed large interindividual variations. In conclusion, prenalterol improves the pump function of the normal heart and causes a fall in peripheral vascular resistance, implying a reduction of the load on the heart. These effects may prove beneficial in the treatment of acute heart failure.
Similar articles
-
Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.Acta Med Scand Suppl. 1982;659:169-80. doi: 10.1111/j.0954-6820.1982.tb00845.x. Acta Med Scand Suppl. 1982. PMID: 6127887
-
Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.Acta Med Scand Suppl. 1982;659:233-50. doi: 10.1111/j.0954-6820.1982.tb00850.x. Acta Med Scand Suppl. 1982. PMID: 6127892
-
Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.Clin Cardiol. 1981 Nov-Dec;4(6):325-9. doi: 10.1002/clc.4960040604. Clin Cardiol. 1981. PMID: 6120057
-
Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.Eur J Clin Pharmacol. 1980 Nov;18(5):383-90. doi: 10.1007/BF00636789. Eur J Clin Pharmacol. 1980. PMID: 6108221 No abstract available.
-
Prenalterol--a new cardioselective inotropic agent.J Clin Hosp Pharm. 1982 Jun;7(2):107-18. doi: 10.1111/j.1365-2710.1982.tb01010.x. J Clin Hosp Pharm. 1982. PMID: 7050180 Review. No abstract available.
Cited by
-
An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.Br J Clin Pharmacol. 1987 Nov;24(5):571-80. doi: 10.1111/j.1365-2125.1987.tb03215.x. Br J Clin Pharmacol. 1987. PMID: 2893634 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources